^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    IMC001

    i
    Other names: IMC001, EPCAM CAR-T, IMC 001, IMC-001
    Associations

    News

    Trials
    Company:
    Immunofoco
    Drug class:
    EpCAM-targeted CAR-T immunotherapy
    Associations

    News

    Trials
    over3years
    EpCAM-targeted CAR-T cell therapy in patients with advanced colorectal and gastric cancers (ESMO 2022)
    IMC001 shows a favorable safety profile and reasonable anti-tumor activities at the initial dosage level in patients with refractory EpCAM+ cancers of digestive system. Updated data from open cohorts will be presented.
    Clinical • CAR T-Cell Therapy
    |
    EPCAM (Epithelial cell adhesion molecule)
    |
    EPCAM expression
    |
    IMC001 • danburstotug (IMC-001)